Genesco Inc (GCO) posted net sales for the third quarter of $713 million, down 1% — falling short of analyst estimates. Comparable sales rose 4%, with stores sales up 4% and direct sales up 9%. Direct-to-consumer sales were 11% of total retail sales for the quarter.
GAAP earnings from continuing operations were $14.5 million in the quarter, compared to a loss of $164.8 million in the third quarter last year.
Net earnings was $14.4 million or $0.73 per diluted share, missing Street estimates of $0.86 per share.
Last quarter, Genesco beat market expectations on revenue and earnings. Net sales then soared 6% to $654 million while, total comparable sales rose 3%, reflecting the highest gain in over two years.
For fiscal 2019, Genesco narrowed its outlook, and now expects comparable sales to be up 2-3%, and adjusted diluted earnings per share of $3.10-3.40.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
